Literature DB >> 30096555

Congenital medulloblastoma: Fetal and postnatal longitudinal observation with quantitative MRI.

Alexandra M Korostyshevskaya1, Andrey A Savelov2, Liudmila I Papusha3, Alexander E Druy3, Vasily L Yarnykh4.   

Abstract

Congenital medulloblastoma is extremely rare. MRI appearance of this tumor in the fetal brain has not been described. A case of congenital medulloblastoma initially observed by antenatal MRI with postnatal follow-up and treatment is presented. A pregnant female underwent fetal MRI on the 31st gestational week for routine indications. Midline cerebellar lesion of ≤2 cm in size with minor T2 hypointensity and T1 hyperintensity was identified. Additionally, quantitative MRI including apparent diffusion coefficient (ADC) and fast macromolecular proton fraction (MPF) mapping was performed. The lesion showed a marked ADC decrease and MPF increase. MPF maps depicted the lesion most conspicuously. After term delivery, a male neonate presented with symptoms of increased intracranial pressure. Postnatal MRI identified obstructive hydrocephalus caused by a large posterior fossa mass. The child was treated by cerebrospinal fluid shunt placement. Follow-up quantitative MRI on the fifth month revealed tumor growth and vivid changes of its tissue contrast associated with brain maturation. The tumor appeared nearly isointense on T1- and T2-weighted images and slightly hypointense on the ADC map. MPF contrast showed the most remarkable change from hyper- to hypointensity due to brain myelination with stable MPF in the tumor. Subsequently, the child underwent partial tumor resection, and currently continues treatment with chemotherapy. The pathological diagnosis was desmoplastic/nodular medulloblastoma. The described case illustrates evolution of the tumor contrast in the course of fetal and postnatal brain development and highlights the added diagnostic value of MPF mapping in fetal and neonatal neuroimaging.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Apparent diffusion coefficient; Congenital tumor; Fetal brain; Macromolecular proton fraction; Magnetic resonance imaging; Medulloblastoma

Mesh:

Year:  2018        PMID: 30096555     DOI: 10.1016/j.clinimag.2018.06.001

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  8 in total

1.  Scan-Rescan Repeatability and Impact of B0 and B1 Field Nonuniformity Corrections in Single-Point Whole-Brain Macromolecular Proton Fraction Mapping.

Authors:  Vasily L Yarnykh; Alena A Kisel; Marina Y Khodanovich
Journal:  J Magn Reson Imaging       Date:  2019-11-18       Impact factor: 4.813

Review 2.  Imaging of fetal brain tumors.

Authors:  Patricia Cornejo; Tamara Feygin; Jennifer Vaughn; Cory M Pfeifer; Alexandra Korostyshevska; Mittun Patel; Dianna M E Bardo; Jeffrey Miller; Luis F Goncalves
Journal:  Pediatr Radiol       Date:  2020-11-30

3.  Data-Driven Retrospective Correction of B1 Field Inhomogeneity in Fast Macromolecular Proton Fraction and R1 Mapping.

Authors:  Vasily L Yarnykh
Journal:  IEEE Trans Med Imaging       Date:  2021-11-30       Impact factor: 10.048

4.  Quantitative Imaging of White and Gray Matter Remyelination in the Cuprizone Demyelination Model Using the Macromolecular Proton Fraction.

Authors:  Marina Khodanovich; Anna Pishchelko; Valentina Glazacheva; Edgar Pan; Andrey Akulov; Mikhail Svetlik; Yana Tyumentseva; Tatyana Anan'ina; Vasily Yarnykh
Journal:  Cells       Date:  2019-10-05       Impact factor: 6.600

5.  Congenital medulloblastoma presented in the neonatal period.

Authors:  Patricio García-Espinosa; Max Molina-Ayala; Edgar Botello-Hernández; Estefania Villareal-Garza; Álvaro Barbosa-Quintana
Journal:  Autops Case Rep       Date:  2021-04-22

Review 6.  Macromolecular Proton Fraction as a Myelin Biomarker: Principles, Validation, and Applications.

Authors:  Alena A Kisel; Anna V Naumova; Vasily L Yarnykh
Journal:  Front Neurosci       Date:  2022-02-09       Impact factor: 5.152

Review 7.  Role of Demyelination in the Persistence of Neurological and Mental Impairments after COVID-19.

Authors:  Marina Y Khodanovich; Daria A Kamaeva; Anna V Naumova
Journal:  Int J Mol Sci       Date:  2022-09-25       Impact factor: 6.208

8.  Long-term monitoring of chronic demyelination and remyelination in a rat ischemic stroke model using macromolecular proton fraction mapping.

Authors:  Marina Yu Khodanovich; Ilya L Gubskiy; Marina S Kudabaeva; Darya D Namestnikova; Alena A Kisel; Tatyana V Anan'ina; Yana A Tumentceva; Lilia R Mustafina; Vasily L Yarnykh
Journal:  J Cereb Blood Flow Metab       Date:  2021-06-09       Impact factor: 6.960

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.